Effect of β-Blockers on β3-Adrenoceptor Expression in Chronic Heart Failure
Authors:
- 18 April 2007
- journal article
- research article
- Published by Springer Nature in Cardiovascular Drugs and Therapy
- Vol. 21 (2) , 85-90
Abstract
To investigate the expression of β3-adrenoceptors in rats with chronic heart failure, and to explore the effect of β-blockers on β3-adrenoceptor expression.Keywords
This publication has 16 references indexed in Scilit:
- ??-Adrenoceptor Antagonists in Elderly Patients with Chronic Heart FailureDrugs & Aging, 2006
- Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS)European Heart Journal, 2005
- Endogenous β3-adrenoreceptor activation contributes to left ventricular and cardiomyocyte dysfunction in heart failureAmerican Journal of Physiology-Heart and Circulatory Physiology, 2004
- What Is the Role of β-Adrenergic Signaling in Heart Failure?Circulation Research, 2003
- ?-Adrenergic stimulation produces a decrease of cardiac contractility ex vivo in mice overexpressing the human ?-adrenergic receptorCardiovascular Research, 2003
- Upregulation of Functional β3-Adrenergic Receptor in the Failing Canine MyocardiumCirculation Research, 2001
- Binding Properties of β-Blockers at Recombinant β1-, β2-, and β3-AdrenoceptorsJournal of Cardiovascular Pharmacology, 2000
- Differential Effects of β-Blockers in Patients With Heart FailureCirculation, 2000
- Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart FailureNew England Journal of Medicine, 1984
- Myosin isoenzyme changes in several models of rat cardiac hypertrophy.Circulation Research, 1981